Navigation Links
Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma
Date:6/2/2008

m tolerated dose (MTD). Further objectives include assessment of safety and tolerability, pharmacocinetics, and antitumor activity of AP 12009. An update of this ongoing study will be presented at the meeting.

AP 12009 and TGF-beta 2

AP 12009 is an antisense drug - a phosphorothioate oligodeoxynucleotide - designed to selectively downregulate the production of transforming growth factor-beta 2 (TGF-beta 2) at the translational level. TGF-beta 2 plays a pivotal role as a multimodally acting cytokine by regulating key mechanisms of tumor progression. Immunosuppression, invasion and migration, proliferation and angiogenesis are simultaneously promoted in a variety of malignant tumors.This multiple impact on cancer cells is inhibited by AP 12009.

About Antisense Pharma GmbH

Antisense Pharma is a biopharmaceutical company located in Regensburg, Germany. The company focuses on targeted therapies for malignant tumors and is dedicated to discovering and developing drugs based on antisense technology for worldwide commercialization. The agents specifically block the synthesis of key cancer proteins. Antisense Pharma has been honored with the Bavarian Innovation Award and the German Founders Award.

Disclaimer

This document contains forward-looking statements with respect to the future business of Antisense Pharma GmbH. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that could occur in the future. There is a number of factors that could cause actual results and developments to differ materially. Antisense Pharma GmbH disclaims any intent of obligation to update any of these forward-looking statements.

Antisense Pharma GmbH

Dr. Heike Specht/Public Relations

Josef-Engert Strasse 9

93053 Regensburg - Germany

Tel.: +49-941-92013-0/ Fax: +49-941-92013-29

E-Mail: pr@antisense-pharma.com

'/>"/>

SOURCE Antisense Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
2. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
3. Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
4. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
5. Amikacin Inhale Shows Promising Results in Phase II Study
6. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
7. New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
8. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
9. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
10. St. Jude Study Shows How T Cells Machinery Dials Down Autoimmunity
11. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin ... been enrolled in the company,s Phase II-b, dose escalation, ... in traumatic brain injury (TBI). Oxycyte is the Company,s ... of invaluable importance in improving the outcome of patients ...
(Date:12/4/2009)... FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: ... medication delivery company, today announced the launch of its ... intravenous (I.V.) medications and solutions, and now offers a ... the award-winning, environmentally responsible VisIV product. The launch of ...
(Date:12/4/2009)... 4 OrthoAccel Technologies, Inc., developers of the ... device to enhance orthodontics, announced the availability of ... PennWell Corporation , a leader in professional education ... The course focuses on patient views about orthodontic ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Red Cross Offers Important Tips for Caring for Someone With the Flu 59551 1Red Cross Offers Important Tips for Caring for Someone With the Flu 59551 2Red Cross Offers Important Tips for Caring for Someone With the Flu 59551 3Dr Oz Host of The Dr Oz Show to Accept Honorary CLIO Healthcare Award Live at Nielsens First Ever CLIO Healthcare Awards Mixer 59549 1Dr Oz Host of The Dr Oz Show to Accept Honorary CLIO Healthcare Award Live at Nielsens First Ever CLIO Healthcare Awards Mixer 59549 2Dr Oz Host of The Dr Oz Show to Accept Honorary CLIO Healthcare Award Live at Nielsens First Ever CLIO Healthcare Awards Mixer 59549 3Institute of Medicine Report Concludes Smoke Free Laws Prevent Heart Attacks 3B Its Time to Make All Workplaces and Public Places Smoke Free 59547 1Institute of Medicine Report Concludes Smoke Free Laws Prevent Heart Attacks 3B Its Time to Make All Workplaces and Public Places Smoke Free 59547 2Institute of Medicine Report Concludes Smoke Free Laws Prevent Heart Attacks 3B Its Time to Make All Workplaces and Public Places Smoke Free 59547 3
... San Francisco Bay research seeks couples ... with male factor ... Center,of the San Francisco Bay Area, in cooperation with ViaCell, ... and effectiveness of,ViaCyte, an investigational product intended to broaden reproductive,options ...
... CRISES - 70 ... Snail Offers Relief for Severe Chronic Pain ... Sufferers, NEW YORK, Sept. ... facing the United States today,impacting the lives of an estimated one in three Americans, ...
Other Medicine Technology:Bay Area Women Sought for Egg Freezing Study 2September is National Pain Awareness Month 2September is National Pain Awareness Month 3September is National Pain Awareness Month 4
(Date:12/7/2009)... Dec. 7 Patricia Scheller, CEO of Prescient ... Galen Institute,s "The Value of Innovation in Health Care" ... 9th in Washington DC at the Columbus Club at ... public policy research organization focusing on health and tax ... the Galen Institute,s conference," said Ms. Scheller. "As the ...
(Date:12/7/2009)... Your Thirst In “Tha Well” – the internet’s first, social ... and disabilities to establish a global presence to learn, care, ... situations while maintaining as much, or as little privacy as ... ... December 4, 2009 – The concept of creating a safe ...
(Date:12/7/2009)... The Cubicle Curtain Factory, ( www.cubiclecurtainfactory.com ... the first major innovation in hospital privacy curtains ... which is already saving hospitals millions in maintenance ... was selected as Agency of Record to elevate ... and social networking media and to create maximum ...
(Date:12/7/2009)... factor most responsible for driving up health ... low-tech strategies to prevent disease and promote ... treat disease after it has arisen," reports ... issue of Explore: The Journal of Science ... can improve health and wellbeing by: ameliorating ...
(Date:12/7/2009)... can estimate their 2009 tax return by using the free tax calculator. Answer ... ... 7, 2009 -- Taxpayers can estimate their 2009 tax return by using the ... use a child could understand it. No more waiting or worrying about how ... is a handy tool everyone can use., , , Find out right now ...
Breaking Medicine News(10 mins):Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:Cubicle Curtain Factory Retains TransMedia Group to Promote First Privacy Curtain to Reduce Hospital Maintenance Cost 2Health News:The Role of Mindfulness Meditation in Health Care Reform 2Health News:The Role of Mindfulness Meditation in Health Care Reform 3Health News:2009 Free Tax Return Calculator 2
... Response Effort, TALLAHASSEE, Fla., Oct. 25 As ... the Capital Area Chapter of,the American Red Cross has ... across the country or around the corner, the Capital ... to tragedy and in this,case, to the devastation caused ...
... Oct. 25 A Video on YouTube (link,below), previews ... to benefit AIDS,Babies. http://www.youtube.com/watch?v=aLRYQk4rcWY A special ... and Truths through this YouTube video and the upcoming ... spiritual adepts comprised of,Knights Templar, Cistercian monks and Sisters ...
... to Have Disproportionate Impact On Latinos, Other ... Medically Underserved ... of St. Luke,s Hospital in San Francisco will have a ... new state,data released today by the California Nurses Association/National Nurses,Organizing ...
... cancer that is being developed is the use of ... normal cells unharmed. These viruses are known as virotherapeutics. ... Jennerex Biotherapeutics, San Francisco, have described the development of ... and rabbits. , After selecting a highly potent strain ...
... A new Center for Excellence in Ethical, Legal ... the University of Pennsylvania School of Medicine, a collaboration ... the Wharton School and the Annenberg School for Communication. ... Genetic Healthcare Technology (Penn CIGHT) will receive over $5 ...
... experts say , THURSDAY, Oct. 25 (HealthDay News) ... promise, researchers say. , Emphysema, a component of ... irreversible lung disease characterized by the destruction of ... new strategy, called airway bypass, is a minimally ...
Other Medicine News:Health News:Capital Area Chapter Deploys Volunteers to California 2Health News:CNA Presents New Data on Sutter's Medical Redlining 2Health News:CNA Presents New Data on Sutter's Medical Redlining 3Health News:Penn wins $5M to start center for ethical, legal and social implications research 2Health News:Penn wins $5M to start center for ethical, legal and social implications research 3
... A necessary addition to ... the Reichert Trial Frame ... and smooth controls for ... robust design, high-quality materials, ...
... The Ultramatic Rx Master is ... years of reliable service and ... that measurably improve procedures. It ... need and want most, including ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
... Illumination is provided by a cool-running, ... light only what you need to see ... best of all they are maintenance free ... light bulb. Every Phoroptor comes with a ...
Medicine Products: